Is the world ready for a diagnostic service that performs a whole genome sequence of embryos conceived by in vitro fertilization? That’s the business plan announced on Dec. 5 by San Francisco-based Orchid Health. In covering this development, Science wrote, “Find the embryo at lowest risk for a disease that runs in your family, touts […]
To access this post, you must purchase The Dark Report.